Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.13 +0.37 (+0.31%)
Official Closing Price Updated: 4:10 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
40 41 Next >
5 Stocks To Watch For April 20, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Earnings Scheduled For April 20, 2022
Companies Reporting Before The Bell • MarketAxess Holdings (NASDAQ:MKTX) is projected to report quarterly earnings at $1.68 per share on revenue of $186.63 million. 
Via Benzinga
4 Stocks With A Perfect Dividend Triangle
Today, we present 4 stocks with a perfect dividend triangle to illustrate how it leads to robust companies. 
Via Talk Markets
Dividend Kings In Focus: AbbVie
A look at AbbVie’s business model, growth potential, and why we rate the stock as a buy for dividend growth investors. 
Via Talk Markets
This Week's Earnings Spotlight: Tesla, Netflix, IBM, American Express, Snap And More
Here are the expected dates and insights into top companies' earnings reports, according to Benzinga Pro. Tuesday after-close: Spirit Airlines Inc (NYSE: SAVE) 
Via Benzinga
If You Invested $1000 In Abbott Laboratories 5 Years Ago, Here's How Much You Would Have Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 8.67% on an annualized basis producing an average annual return of 21.94%. Currently, Abbott Laboratories has a... 
Via Benzinga
Earnings Preview: Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-04-20. Here's what investors need to know before the announcement. Analysts estimate that Abbott... 
Via Benzinga
Food Commodities Continue to Rise — Learn Who May Benefit
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting... 
Via Benzinga
Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings
Via Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 28.81% since its last report. The company recently reported that it has 13.33 million shares sold short, which is... 
Via Benzinga
Best Stocks for 2022: Up 20% This Year, AbbVie Is Doing Great
AbbVie is great for dividend investors, and it's great for people looking for growth in 2022. The company's guidance for 2022 is exciting. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.51% on an annualized basis producing an average annual return of 15.1%. Currently, Abbott Laboratories has a... 
Via Benzinga
Abbott Laboratories Whale Trades For March 29
A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 11 strange trades. 
Via Benzinga
FDA Inspection Flags Quality Control Issues At Abbott's Michigan Facility
An inspection at the Abbott Laboratories (NYSE: ABT) facility in Sturgis, Michigan,  
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 15.69% since its last report. The company recently reported that it has 10.37 million shares sold short, which is... 
Via Benzinga
A Bearish Sign Appears On Abbott Laboratories's Chart
If history is any guide, there may be trouble ahead for shares of Abbott Laboratories (NYSE:ABT). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia
Eli Lilly And Co (NYSE: LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines." 
Via Benzinga
CNBC's Final Trades: Interactive Brokers, Abbott Laboratories, Apple And This REIT Stock
On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners chose Interactive Brokers Group, Inc. (NASDAQ: IBKR) as his top pick. 
Via Benzinga
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 3.32% on an annualized basis. Buying $1,000 In ABT: 10 years ago, an investor could have... 
Via Benzinga
10 More Major US Corporations Still Doing Business In Russia
The flow of U.S. companies exiting Russia has intensified as President Vladimir Putin’s military continues to lay waste to Ukraine. But while more than 300 major companies... 
Via Benzinga
Dividend Income Update February 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolios. 
Via Talk Markets
7 Long-Term Stocks to Buy Now and Hold Forever
Here are seven long-term stocks that fit well in most investors' portfolios as core holdings over decades, at least historically speaking. 7 Long-Term Stocks to Buy Now and Hold Forever 
Via InvestorPlace
36 Stocks To Watch After Biden's First State of The Union Address
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped... 
Via Benzinga
Abbott's CardioMEMS HF System Scores FDA Nod For Earlier-Stage Heart Failure
The FDA has approved an expanded indication for Abbott Laboratories' (NYSE: ABT) CardioMEMS HF System. The CardioMEMS HF System was initially... 
Via Benzinga
Half The American Population May Suffer From Chronic Illnesses By 2025, According To This Report
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. If you think the... 
Via Benzinga
Abbott Labs Outlook Cools the Omicron Led Testing Boom
Photo by Adam Nieścioruk on Unsplash 
Via Benzinga
Stock Market Whipsaws Lower On Hawkish Fed, Tesla; Apple, Microsoft Earnings Strong: Weekly Review
Microsoft and Apple earnings were strong, but the correction is getting worse. 
Via Investor's Business Daily
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.